These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 767354)

  • 1. Effect of cyproterone acetate therapy on gonadotropin response to synthetic luteinizing hormone-releasing hormone (LRH) in girls with idiopathic precocious puberty.
    Angeli A; Boccuzzi G; Bisbocci D; Fonzo D; Frajria R; DeSanctis C; Ceresa F
    J Clin Endocrinol Metab; 1976 Mar; 42(3):551-60. PubMed ID: 767354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Responsivity of pituitary gonadotropes to luteinizing hormone-releasing factor in idiopathic precocious puberty, precocious thelarche, precocious adrenarche, and in patients treated with medroxyprogesterone acetate.
    Reiter EO; Kaplan SL; Conte FA; Grumbach MM
    Pediatr Res; 1975 Feb; 9(2):111-6. PubMed ID: 1090891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The LH and FSH responses to LH-releasing hormone (LH-RH) in girls with true precocious puberty treated with cyproterone acetate.
    Kauli R; Prager-Lewin R; Keret R; Laron Z
    Eur J Pediatr; 1977 Jul; 125(3):205-12. PubMed ID: 328285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged pulsatile administration of luteinizing hormone-releasing hormone in prepubertal children: diagnostic and physiologic aspects.
    Delemarre-van de Waal HA; Van den Brande JL; Schoemaker J
    J Clin Endocrinol Metab; 1985 Nov; 61(5):859-67. PubMed ID: 3930552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long term treatment of male and female precocious puberty by periodic administration of a long-acting preparation of D-Trp6-luteinizing hormone-releasing hormone microcapsules.
    Roger M; Chaussain JL; Berlier P; Bost M; Canlorbe P; Colle M; Francois R; Garandeau P; Lahlou N; Morel Y
    J Clin Endocrinol Metab; 1986 Apr; 62(4):670-7. PubMed ID: 2936759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathophysiology of gonadotropin secretion in patients with idiopathic precocious puberty and follow up studies during and after therapy with medroxyprogesterone acetate (author's transl)].
    Aono T; Minagawa J; Terakawa N; Kurachi K; Matsumoto K
    Nihon Naibunpi Gakkai Zasshi; 1975 Nov; 51(11):898-907. PubMed ID: 1241847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The response of pituitary gonadotropes to a constant infusion of luteinizing hormone-releasing hormone (LHRH) in normal prepubertal and pubertal children and in children with abnormalities of sexual development.
    Reiter EO; Root AW; Duckett GE
    J Clin Endocrinol Metab; 1976 Aug; 43(2):400-11. PubMed ID: 780368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of medroxyprogesterone acetate on gonadotropin secretion in girls with precocious puberty.
    Warren MP; Mathews JH; Morishima A; Vande Wiele R
    Am J Med Sci; 1975; 269(3):375-81. PubMed ID: 1155493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma gonadotropin (LH and FSH) concentrations in repubertal and pubertal children upon stimulation by LH-releasing hormone.
    Lovrencić MK; Banovac ZR; Oberiter V; Sekso M; Petek M; Skrabalo LK; Resetić J
    Helv Paediatr Acta; 1975 Oct; 30(3):232-8. PubMed ID: 1102497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Luteinizing hormone-releasing hormone analog treatment of boys with hypothalamic hamartoma and true precocious puberty.
    Comite F; Pescovitz OH; Rieth KG; Dwyer AJ; Hench K; McNemar A; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1984 Nov; 59(5):888-92. PubMed ID: 6434587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of estrogen and progesterone on the functional capacity of the gonadotrophs.
    Lasley BL; Wang CF; Yen SS
    J Clin Endocrinol Metab; 1975 Nov; 41(5):820-6. PubMed ID: 1102551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty.
    Feuillan PP; Jones JV; Barnes K; Oerter-Klein K; Cutler GB
    J Clin Endocrinol Metab; 1999 Jan; 84(1):44-9. PubMed ID: 9920060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Premature thelarche and central precocious puberty: the relationship between clinical presentation and the gonadotropin response to luteinizing hormone-releasing hormone.
    Pescovitz OH; Hench KD; Barnes KM; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1988 Sep; 67(3):474-9. PubMed ID: 3137242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate).
    Juul A; Scheike T; Nielsen CT; Krabbe S; Müller J; Skakkebaek NE
    J Clin Endocrinol Metab; 1995 Oct; 80(10):3059-67. PubMed ID: 7559897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The LH response to LH releasing hormone in children with true isosexual precocious puberty treated with cyproterone acetate.
    Kauli R; Prager-Lewin R; Keret R; Laron Z
    Clin Endocrinol (Oxf); 1975 May; 4(3):305-11. PubMed ID: 1097137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of gonadotropins to stimulation with luteinizing hormone -- releasing hormone (LH-RH) in children with precocious puberty before, during and following therapy with cyproterone acetate or an ethisterone derivate.
    Frisch H; Kemeter P; Steinert I
    Padiatr Padol Suppl; 1977; (5):121-8. PubMed ID: 199874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary responses to LRH in the postpartum periods.
    Friedman C; Gaeke ME; Fang V; Kim MH
    Am J Obstet Gynecol; 1976 Jan; 124(1):75-9. PubMed ID: 1106206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of true precocious puberty with a potent luteinizing hormone-releasing factor agonist: effect on growth, sexual maturation, pelvic sonography, and the hypothalamic-pituitary-gonadal axis.
    Styne DM; Harris DA; Egli CA; Conte FA; Kaplan SL; Rivier J; Vale W; Grumbach MM
    J Clin Endocrinol Metab; 1985 Jul; 61(1):142-51. PubMed ID: 3923027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gonadotropin and sex steroid response to luteinizing hormone-releasing hormone in patients with premature adrenarche.
    Lee PA; Gareis FJ
    J Clin Endocrinol Metab; 1976 Jul; 43(1):195-7. PubMed ID: 780365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between integrated LH and FSH levels and the response to luteinizing hormone relasing factor (LRF).
    Mortimer RH; Fleischer N; Lev-Gur M; Freeman RG
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1240-9. PubMed ID: 794076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.